This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 9 from Patent US 20030077289
General Information
DRACP ID DRACP01236
Peptide Name Sequence 9 from Patent US 20030077289
Sequence PLSSIFSRIGDP
Sequence Length 12
PubChem CID Not available
Origin Hepatitis B virus
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C58H93N15O18
Absent amino acids ACEHKMNQTVWY
Common amino acids S
Mass 148484
Pl 6.34
Basic residues 1
Acidic residues 1
Hydrophobic residues 4
Net charge 0
Boman Index -1516
Hydrophobicity 13.33
Aliphatic Index 97.5
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2003/0077289 A1
Patent Title Use of cell-penetrating peptides to generate antitumor immunity.
Other Iinformation Granted Patent Family: 6s / 6ex; Family Jurisdictions: CN, WO, AU, US; Legal Status: Discontinued; Application No: 7755502; Filed:Feb 15, 2002; Published: Apr 24, 2003; Earliest Priority: Feb 15, 2001
Other Published ID CN1309417C CN1503628A WO2002064057A2 WO2002064057A3
This work is licensed under a Creative Commons Attribution 4.0 International License.